RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
  Neonatology
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Paediatrics Channel

subscribe to Paediatrics newsletter
Latest Research : Paediatrics

   EMAIL   |   PRINT
New 'eye movement' test to identify children with Fetal Alcohol Spectrum Disorder (FASD)

Nov 12, 2005 - 7:55:00 PM
"Having access to this facility will have a huge impact on our research program. It allows us to create an integrated research strategy for carrying out studies to provide functional brain imaging data that can be directly related to neuro-behavioural deficits in individual children with FASD."

 
[RxPG] A simple test that measures eye movement may help to identify children with Fetal Alcohol Spectrum Disorder (FASD) and ultimately lead to improved treatment for the condition, say Queen's University researchers.

At present there are no objective diagnostic tools that can be used to distinguish between children with FASD – which affects approximately one per cent of children in Canada – and those with other developmental disorders such as Attention-Deficit Hyperactivity Disorder (ADHD).

Researcher James Reynolds and graduate student Courtney Green, of the Department of Pharmacology and Toxicology and the Centre for Neuroscience Studies, will present their findings next week at the annual meeting of the international Society for Neuroscience in Washington, D.C.

"Having a set of tests that can be used as diagnostic tools for fetal alcohol syndrome and all of the other behavioural disorders classified under the broader term fetal alcohol spectrum disorder is tremendously valuable," says Dr. Reynolds, who is part of a $1.25-million Queen's-led team focusing on fetal alcohol syndrome, funded by the Canadian Institutes of Health Research. "Now we can begin to identify specific deficits in these children."

Many of the behavioural tests used to assess children with FASD are geared to white, middle-class English-speaking people, notes Ms Green. "The biggest problem [in current tests] is cultural insensitivity," she says. "By measuring eye movement we can cut across cultural barriers and provide objectivity in identifying the disorder."

In a pilot study involving 25 girls and boys aged eight to 12, the Queen's team found that children with FASD have specific brain abnormalities which can be measured with eye movement testing. Defined as "birth defects resulting from a mother's consumption of alcohol during pregnancy", fetal alcohol syndrome is associated with hyperactivity, difficulty in learning and deficits in memory, understanding and reasoning, as well as problems dealing with stressful situations.

The next stage of the Queen's research will be to make the eye movement test mobile and transport it to targeted areas, such as northern and rural parts of Ontario, where FASD is believed to be more prevalent. The researchers envision this as a multi-centre project, in which other participants will work from the same set of pooled data.

"There is a clear need to develop new tools that can be used to reliably and objectively measure the brain injury of FASD," says Dr. Reynolds. "Ideally, these tools need to be mobile, inexpensive, and easy to use, for both diagnosis and the long-term evaluation of therapeutic interventions. Eye movements are ideally suited for this purpose."

Using the new functional MRI facility at Queen's, the team will then be able to measure differences in brain activity between children with fetal alcohol syndrome and those with other developmental disorders such as ADHD.

"Having access to this facility will have a huge impact on our research program," Dr. Reynolds says. "It allows us to create an integrated research strategy for carrying out studies to provide functional brain imaging data that can be directly related to neuro-behavioural deficits in individual children with FASD."



Publication: Society for Neuroscience Meeting
On the web: Queen's University 

Advertise in this space for $10 per month. Contact us today.


Related Paediatrics News
Breathing new life into preterm baby research
Penn Medicine study: Proton therapy cuts side effects for pediatric head and neck cancer patients
NJ State House honors NJIT student inventors of autism app
Researchers from Mount Sinai receive NIH grant to study promising treatment for Autism subtype
Brain size may signal risk of developing an eating disorder
Chromosome 21 abnormality tells oncologists to treat pediatric ALL more aggressively
HudsonAlpha awarded grant to improve diagnoses of childhood genetic disorders
Insights into how brain compensates for recurring hearing loss point to new glue ear therapies
CWRU study finds babies witnessing violence show aggression later in school
Mayo Clinic first in US to test stem cells in pediatric congenital heart disease patients

Subscribe to Paediatrics Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)